Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Ramucirumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Stomach Neoplasms 11 Lung Neoplasms 6 Esophageal Neoplasms 4 Neoplasm Metastasis 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thymoma 1 Solid Tumors 1 Solid Cancer 1 Sarcoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Metastatic Small Intestinal Adenocarcinoma 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Digestive System Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡